Medicared For All Logo

Jeffrey Sykes in Sioux City, Iowa

Home Iowa Sioux City

Jeffrey Sykes has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 2730 Pierce St in Sioux City, Iowa. There is an additional office location, for a total of two, for Jeffrey Sykes that can be viewed further down.

They're a part of the: Northwest Iowa Hospital Corporation medical group which has around 43 members. You can call their office at 712-239-4702 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Michigan State University College Of Human Medicine and graduated in 1993 (around 31 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Jeffrey S Sykes Office Phone and Directions

Jeffrey Sykes
Northwest Iowa Hospital Corporation
2730 Pierce St
Sioux City, Iowa 51104
712-239-4702


Patient Ratings
Please rate your experience with Jeffrey Sykes below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 712-239-4702


Enter a starting address:


Healthcare Info for Jeffrey Sykes

Medical School: Michigan State University College Of Human Medicine
Graduation Year: 1993
The Primary Medical Specialty for Jeffrey Sykes is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 31
PAC (PECOS ID)#: 6406940998
NPI #: 1649244682
NPI Created On: 02/15/2006
NPI Last Updated Listed as: 10/15/2015
Primary Taxonomy Code: 207RC0000X
License Number:
MD-33097
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Sanford Health Plan
  • Avera Health Plans, Inc.
  • Medica Insurance Company
  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. External ekg recording for more than 48 hours up to 21 days
  2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  4. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  7. Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report
  8. Evaluation of defibrillator including connection, recording and disconnection
  9. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
  10. Remote evaluations of defibrillator up to 90 days with analysis, review and report
  11. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  12. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  13. Follow-up or limited ultrasound examination of heart
  14. Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers
  15. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
  16. Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
  17. New patient office or other outpatient visit, typically 45 minutes
  18. New patient office or other outpatient visit, typically 60 minutes
  19. Established patient office or other outpatient visit, typically 15 minutes
  20. Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788517705

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768804914

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848591735

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: VERQUVO

Open Associated Drug #1: 0006-5030-01


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763674732

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DIABETES

Name of Drug #1: JARDIANCE

Open Associated Drug #1: 0597-0152-30


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 838417581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTILIPEMIC AGENTS

Name of Drug #1: NEXLIZET

Open Associated Drug #1: 72426-818-03

Drug or Biological: Drug

Product Category #2: ANTILIPEMIC AGENTS

Name Of Drug #2:: NEXLETOL

Associated Drug #2: 72426-118-03


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829768365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Additional Office Locations

1. Northwest Iowa Hospital Corporation
5885 Sunnybrook Dr
Sioux City, IA 51106
Suite L200
Group Members: 43

Phone: 712-239-4702

Enter a starting address:


Cardiovascular Disease (cardiology) Professionals in Sioux City

2720 Stone Park Blvd
Sioux-city, IA
Northwest Iowa Hospital Corporation

801 5th St
Sioux-city, IA
Mercy Medical Services

509 7th St
Sioux-city, IA

801 5th St
Sioux-city, IA
Mercy Medical Services

2730 Pierce St
Sioux-city, IA
Northwest Iowa Hospital Corporation

5885 Sunnybrook Dr
Sioux-city, IA
Northwest Iowa Hospital Corporation

Providers in Northwest Iowa Hospital Corporation

1.Roque Arteaga

2720 Stone Park Blvd
Sioux City Ia 51104-3734
Northwest Iowa Hospital Corporation
Cardiovascular Disease (cardiology)

2.Nicole Batcheller

5885 Sunnybrook Dr
Sioux City Ia 51106-4251
Northwest Iowa Hospital Corporation
Nurse Practitioner

3.Sandra Birchem Do

2720 Stone Park Blvd
Sioux City Ia 51104-3734
Northwest Iowa Hospital Corporation
Internal Medicine

4.Mario Christianto

2720 Stone Park Blvd
Sioux City Ia 51104-3734
Northwest Iowa Hospital Corporation
Critical Care (intensivists)

5.Annalisa Cunningham

2730 Pierce St
Sioux City Ia 51104-3796
Northwest Iowa Hospital Corporation
Nurse Practitioner

6.Annalisa Cunningham

5885 Sunnybrook Dr
Sioux City Ia 51106-4251
Northwest Iowa Hospital Corporation
Nurse Practitioner

View all 43 members of Northwest Iowa Hospital Corporation medical group